Skip to main content
. 2022 Dec 23;12(1):62. doi: 10.3390/cells12010062

Figure 6.

Figure 6

Depleting PCSK9 impairs liver tumor development in vivo. In zebrafish experiments: tomato red fluorescent labeled HepG2 with shPCSK9 or the control were xenografted in zebrafish embryos. Tumoral cell growth was evaluated by the quantification of the fluorescence 24 and 48 h post-injection (hpi). Unpaired t-test, *: p < 0.05, ****: p < 0.0001.